Outcomes of Broader Genomic Profiling in Metastatic Colorectal Cancer: A Portuguese Cohort Study

Outcomes of Broader Genomic Profiling in Metastatic Colorectal Cancer: A Portuguese Cohort Study

Background: Colorectal cancer (CRC) is the third most diagnosed cancer globally and the second leading cause of cancer-related deaths. Despite advancements, metastatic CRC (mCRC) has a five-year survival rate below 20%. Next-generation sequencing (NGS) is recommended nowadays to guide mCRC treatment...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ricardo Roque, Rita Santos, Luís Guilherme Santos, Rita Coelho, Isabel Fernandes, Gonçalo Cunha, Marta Gonçalves, Teresa Fraga, Judy Paulo, Nuno Bonito
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	DNA
Subjects:	next-generation sequencing colorectal cancer actionable variants targeted treatments real-world data
Online Access:	https://www.mdpi.com/2673-8856/5/1/4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Integrating next-generation sequencing and artificial intelligence for the identification and validation of pathogenic variants in colorectal cancer
by: Juliana Rodriguez-Salamanca, et al.
Published: (2025-05-01)

Overexpression of Osteopontin-a and Osteopontin-c Splice Variants Are Worse Prognostic Features in Colorectal Cancer
by: Daniella Mattos, et al.
Published: (2024-09-01)

The Role of the Gut Microbiota in the Development of Colorectal Cancer
by: V. N. Shumilova, et al.
Published: (2024-03-01)

Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data
by: M.J. Emmett, et al.
Published: (2024-06-01)

A compilation of 13 patients with metastatic colorectal cancer and concomitant BRAF and RAS family mutations
by: Jigisha Srivastav, et al.
Published: (2025-08-01)

Mutational profile of KRAS-positive colorectal cancer
by: E. N. Telysheva, et al.
Published: (2022-03-01)

Analytical and clinical validation of a NGS panel in detecting targetable variants from ctDNA of metastatic NSCLC patients
by: Feifei Fan, et al.
Published: (2024-10-01)

Applications and perspectives of metastatic colorectal cancer organoids
by: CUI Jingwei, et al.
Published: (2024-06-01)

Comparison of somatic mutations and clinicopathologic features of micropapillary and non-micropapillary colorectal carcinomas
by: Zeynep Sagnak Yilmaz, et al.
Published: (2025-07-01)

Analysis of the multigene molecular panel for colorectal cancer in patients under 50 years of age – the preliminary results of the Polish department
by: Monika Kozłowska-Geller, et al.
Published: (2024-11-01)

Differentially expressed lncRNAs and mRNAs identified by NGS analysis in colorectal cancer patients
by: Meng Li, et al.
Published: (2018-09-01)

Association between genomic features and toxic metal(loid) accumulation in left-sided and right-sided colorectal cancer
by: Shoujiang Yu, et al.
Published: (2025-07-01)

Colorectal cancer vaccines: in silico identification of tumor-specific antigens associated with frequent HLA-I alleles in the costa rican Central Valley population
by: Diego Morazán-Fernández, et al.
Published: (2022-11-01)

KRAS amplification in colorectal cancer: correlations with clinicopathological features and prognosis in patients and prediction of response to targeted therapy
by: Xuanhua Yang, et al.
Published: (2025-07-01)

TO THE PROBLEM OF CHOICE OF THE TREATMENT TACTICS IN METASTATIC COLORECTAL CANCE
by: A. Z. Azanov, et al.
Published: (2016-04-01)

Molecular characterization of colorectal cancer (CRC) using next generation sequencing (NGS) in bridging the gap between research and clinical practice: from biomarker discovery to clinical implementation
by: Hafeez Abiola Afolabi, et al.
Published: (2025-03-01)

The RASAL2 variant promotes aberrant RAS signaling and resistance to anti-EGFR therapy in colorectal cancer
by: Yu-Min Yeh, et al.
Published: (2025-08-01)

Brazilian cohort results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer
by: Celso Abdon Lopes de Mello, et al.
Published: (2022-12-01)

Progress on the mechanism of intestinal microbiota against colorectal cancer
by: Guoqiang Xing, et al.
Published: (2025-04-01)

Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
by: Maria Ignez Freitas Melro Braghiroli, et al.
Published: (2024-01-01)

Colorectal Cancer with Uncommon Metastatic Spread
by: Luca Dellavedova, et al.
Published: (2015-07-01)

Treatment sequencing in metastatic colorectal cancer
by: Nanteznta Torounidou, et al.
Published: (2025-01-01)

Research Progress on the Role of Zinc Finger Protein in Colorectal Cancer
by: Tang Yu, et al.
Published: (2025-03-01)

Precise detection of differential RNA editing sites across varied biological conditions using the CADRES pipeline
by: Jun Sun, et al.
Published: (2025-06-01)

Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer
by: Yu. Yu. Petukhova, et al.
Published: (2021-10-01)

Germline variants in patients from the Iranian hereditary colorectal cancer registry
by: Lena Goshayeshi, et al.
Published: (2025-04-01)

Do Colorectal Serrated and Non-Serrated Adenocarcinomas Differ in Somatic Mutations and Clinicopathologic Features?
by: Zeynep Sagnak Yilmaz, et al.
Published: (2025-06-01)

Selective depletion of metastatic stem cells as therapy for human colorectal cancer
by: María Virtudes Céspedes, et al.
Published: (2018-09-01)

Molecular Genetics of Renal Cell Carcinoma: A Narrative Review Focused on Clinical Relevance
by: Braden Millan, et al.
Published: (2025-06-01)

How opportune is multigene testing in metastatic colorectal cancer? A review
by: Cristina Orlov-Slavu, et al.
Published: (2021-10-01)

Diagnostic yield of expanded carrier screening of a multi-ethnic population in yunnan, China
by: Huizi Wang, et al.
Published: (2025-07-01)

Regional patterns of genetic variants in expanded carrier screening: a next-generation sequencing pilot study in Fujian Province, China
by: Danhua Guo, et al.
Published: (2025-05-01)

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2019-12-01)

Modern strategy of metastatic colorectal cancer treatment (literature review)
by: O. I. Kit, et al.
Published: (2024-09-01)

Nivolumab monotherapy in metastatic colorectal cancer: current approaches to response evaluation
by: N. N. Babyshkina, et al.
Published: (2022-11-01)

Electrochemotherapy in the Locoregional Treatment of Metastatic Colorectal Liver Metastases: A Systematic Review
by: Pierluigi Barbieri, et al.
Published: (2024-11-01)

Limited Efficacy of Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients with Rare RAS Variants: Analysis of the C-CAT Database
by: Shuhei Suzuki, et al.
Published: (2024-12-01)

The prognostic importance of the global immune-nutrition-information index (GINI) in patients with Ras wild type metastatic colorectal cancer
by: Oktay Bozkurt, et al.
Published: (2025-07-01)

Variability in surgical treatment of metastatic colorectal cancer (literature review)
by: A. Yu. Dobrodeev, et al.
Published: (2023-05-01)

CLINICAL CASE OF A MASSIVE ISOLA TED METASTATIC ADRENAL LESION IN COLORECT AL CANCER
by: I. P. Moshurov, et al.
Published: (2015-10-01)